Depending on a variety of factors, there are various options for the treatment of genitourinary cancers (included bladder, kidney, and prostate cancers) including immunotherapy. This guide, published by Patient Resource Publishing in partnership with the Society for Immunotherapy of Cancer (SITC), provides information on current immunotherapy options for bladder, kidney, and prostate cancers, and explains the role of the immune system in cancer treatment and what to expect while undergoing treatment. Published 2020.#ClinicalTrials#BladderCancer#GenitourinaryCancers#ProstateCancer#PatientResourceGuides#AdverseEvents#SideEffects#Patient#PatientAdvocate#ImmuneCheckpointInhibitors#Cytokines#Vaccines#RenalCellCarcinoma#Pembrolizumab#Tcells#Bcells#Atezolizumab#Avelumab#Durvalumab#Nivolumab#Naturalkillercells
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us